Vestal Point Capital’s DexCom DXCM Stock Holding History

Vestal Point Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,275,000	Closed	-$84.6M	–	98
2025 Q4	$84.6M	Buy	1,275,000 +625,000	+96%	+$40.4M	2.88%	9
2025 Q3	$43.7M	Buy	+650,000	New	+$51.4M	1.98%	18

Other funds holding DXCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vestal Point Capital's DXCM Position: Q1 2026 in Review

Vestal Point Capital sold out of DexCom (DXCM) in Q1 2026, closing a stake of 1,275,000 shares — an estimated $84.6M sold.

Vestal Point Capital first reported a position in DXCM in Q3 2025 and held it in 2 quarters. The position peaked at $84.6M in Q4 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Vestal Point Capital reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Vestal Point Capital sold 1,275,000 DexCom shares in Q1 2026, an estimated $84.6M.
Vestal Point Capital first reported a position in DexCom in Q3 2025 and held it in 2 quarters.
Vestal Point Capital's DexCom position peaked at $84.6M in Q4 2025.
957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.